|
1
|
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
|
Ann Neurol
|
2005
|
3.09
|
|
2
|
Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions.
|
Sleep
|
2004
|
2.88
|
|
3
|
NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea.
|
Am J Respir Crit Care Med
|
2005
|
1.91
|
|
4
|
Inducible nitric oxide synthase in long-term intermittent hypoxia: hypersomnolence and brain injury.
|
Am J Respir Crit Care Med
|
2005
|
1.80
|
|
5
|
Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output.
|
Am J Respir Crit Care Med
|
2004
|
1.76
|
|
6
|
Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
|
Biol Psychiatry
|
2007
|
1.68
|
|
7
|
Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells.
|
Exp Hematol
|
2002
|
1.64
|
|
8
|
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.
|
Neurobiol Aging
|
2007
|
1.61
|
|
9
|
Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD.
|
Invest Ophthalmol Vis Sci
|
2008
|
1.47
|
|
10
|
High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.
|
Endocrinology
|
2013
|
1.46
|
|
11
|
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.
|
Am J Psychiatry
|
2012
|
1.43
|
|
12
|
The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration.
|
Invest Ophthalmol Vis Sci
|
2011
|
1.37
|
|
13
|
Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia.
|
Alzheimers Dement
|
2006
|
1.34
|
|
14
|
Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
|
Hepatology
|
2010
|
1.27
|
|
15
|
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.
|
J Alzheimers Dis
|
2009
|
1.26
|
|
16
|
Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice.
|
Mol Neurodegener
|
2012
|
1.22
|
|
17
|
Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
|
Arterioscler Thromb Vasc Biol
|
2003
|
1.12
|
|
18
|
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.
|
Trends Pharmacol Sci
|
2005
|
1.09
|
|
19
|
Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
|
J Lipid Res
|
2005
|
1.09
|
|
20
|
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.
|
Neurobiol Aging
|
2007
|
1.07
|
|
21
|
Coxibs and cardiovascular side-effects: from light to shadow.
|
Curr Pharm Des
|
2006
|
1.03
|
|
22
|
From the design to the clinical application of thromboxane modulators.
|
Curr Pharm Des
|
2006
|
1.01
|
|
23
|
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.
|
Biol Psychiatry
|
2010
|
0.98
|
|
24
|
Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice.
|
J Neurosci
|
2008
|
0.97
|
|
25
|
Adverse cardiovascular effects of the coxibs.
|
J Med Chem
|
2005
|
0.95
|
|
26
|
Total synthesis of 8,12-iso-iPF3alpha-VI, an EPA-derived isoprostane: stereoselective introduction of the fifth asymmetric center.
|
J Org Chem
|
2006
|
0.92
|
|
27
|
Oxidative stress and cognitive ability in adults with Down syndrome.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2008
|
0.91
|
|
28
|
Potentially reduced exposure cigarettes accelerate atherosclerosis: evidence for the role of nicotine.
|
Cardiovasc Toxicol
|
2007
|
0.90
|
|
29
|
Isoprostane F2alpha-VI, a new marker of oxidative stress, increases following light damage to the mouse retina.
|
Mol Vis
|
2007
|
0.85
|
|
30
|
Sex differences in susceptibility to oxidative injury and sleepiness from intermittent hypoxia.
|
Sleep
|
2006
|
0.84
|
|
31
|
Dual carbonic anhydrase--cyclooxygenase-2 inhibitors.
|
Curr Top Med Chem
|
2007
|
0.83
|
|
32
|
Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations.
|
Dement Geriatr Cogn Disord
|
2012
|
0.82
|
|
33
|
Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease.
|
J Mol Med (Berl)
|
2009
|
0.81
|
|
34
|
F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients.
|
Cogn Behav Neurol
|
2008
|
0.81
|
|
35
|
High-dose B vitamin supplements and Alzheimer disease.
|
JAMA
|
2009
|
0.78
|
|
36
|
iPF2alpha-III-17,18,19,20-d4: total synthesis and metabolism.
|
Bioorg Med Chem Lett
|
2005
|
0.77
|